Suppr超能文献

老年患者经皮冠状动脉介入治疗围术期出血与长期预后的关系。

Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients.

机构信息

Duke Clinical Research Institute, Durham, North Carolina 27705, USA.

出版信息

JACC Cardiovasc Interv. 2012 Sep;5(9):958-65. doi: 10.1016/j.jcin.2012.05.010.

Abstract

OBJECTIVES

The authors sought to describe the association between post-procedural bleeding and long-term recurrent bleeding, major adverse cardiac events (MACE), and mortality among older patients undergoing percutaneous coronary intervention (PCI).

BACKGROUND

Bleeding complications after PCI are associated with an increased risk for acute morbidity and long-term mortality, but the association of these bleeding complications with other events is unknown.

METHODS

Patients entered into the National Cardiovascular Data Registry (NCDR) CathPCI Registry (n = 461,311; 946 sites) from January 2004 to December 2008 were linked with claims from the Centers for Medicare & Medicaid Services and grouped according to in-hospital post-PCI bleeding. The association between post-PCI bleeding and 1-, 12-, and 30-month readmission for bleeding, MACE, and all-cause mortality was examined with Cox regression that included patient and procedural characteristics using no bleeding as the reference.

RESULTS

Overall, 3.1% (n = 14,107) of patients experienced post-PCI bleeding. Patients who bled were older, more often female, had more medical comorbidities, less often received bivalirudin, and more often underwent PCI via the femoral approach. After adjustment, bleeding after the index procedure was significantly associated with readmission for bleeding (adjusted hazard ratios [95% confidence interval]: 1 month, 1.54 [1.42 to 1.67]; 12 months, 1.52 [1.40 to 1.66]; 30 months, 1.29 [1.11 to 1.50]), MACE (1 month, 1.11 [1.07 to 1.15]; 12 months, 1.17 [1.13 to 1.21]; 30 months, 1.12 [1.06 to 1.19]) and all-cause mortality (1 month, 1.32 [1.26 to 1.38]; 12 months, 1.33 [1.27 to 1.40]); 30 months, 1.22 [1.15 to 1.30]).

CONCLUSIONS

Post-PCI bleeding complications are associated with an increased risk for short- and long-term recurrent bleeding, MACE, and all-cause mortality. These data underscore the prognostic importance of periprocedural bleeding and the need for identifying strategies to reduce long-term bleeding risk among patients undergoing PCI.

摘要

目的

本研究旨在描述老年经皮冠状动脉介入治疗(PCI)患者术后出血与长期复发性出血、主要不良心脏事件(MACE)和死亡率之间的关系。

背景

PCI 后出血并发症与急性发病率和长期死亡率增加相关,但这些出血并发症与其他事件的关系尚不清楚。

方法

本研究纳入 2004 年 1 月至 2008 年 12 月期间在国家心血管数据注册库(NCDR)CathPCI 注册库(n=461311;946 个中心)中登记的患者,并与医疗保险和医疗补助服务中心的索赔数据进行了关联,并根据住院期间 PCI 后的出血情况进行了分组。采用 Cox 回归分析,将患者和手术特征纳入其中,以无出血作为参考,评估 PCI 后出血与 1、12 和 30 个月时因出血、MACE 和全因死亡率而再次入院之间的关系。

结果

总体而言,3.1%(n=14107)的患者发生了 PCI 后出血。出血患者年龄较大,女性较多,合并症较多,较少接受比伐卢定治疗,更多采用股动脉入路进行 PCI。经调整后,指数手术后出血与再次出血入院(校正后的危险比[95%置信区间]:1 个月 1.54[1.42 至 1.67];12 个月 1.52[1.40 至 1.66];30 个月 1.29[1.11 至 1.50])、MACE(1 个月 1.11[1.07 至 1.15];12 个月 1.17[1.13 至 1.21];30 个月 1.12[1.06 至 1.19])和全因死亡率(1 个月 1.32[1.26 至 1.38];12 个月 1.33[1.27 至 1.40];30 个月 1.22[1.15 至 1.30])显著相关。

结论

PCI 后出血并发症与短期和长期复发性出血、MACE 和全因死亡率增加相关。这些数据强调了围手术期出血的预后重要性,以及需要确定策略来降低接受 PCI 治疗的患者的长期出血风险。

相似文献

引用本文的文献

本文引用的文献

1
Rivaroxaban in patients with a recent acute coronary syndrome.利伐沙班用于近期急性冠状动脉综合征患者。
N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.
8
Anticoagulant therapy for percutaneous coronary intervention.经皮冠状动脉介入治疗的抗凝治疗
Circ Cardiovasc Interv. 2010 Feb 1;3(1):80-8. doi: 10.1161/CIRCINTERVENTIONS.109.884478.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验